Rush Medical Foundation
Rush Medical Foundation was paid $4.69M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.
QUITMAN, MS 39355
Next to other Critical Access Hospital providers in Mississippi
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,924 | $978K | |
| 2019 | 16,567 | $829K | |
| 2020 | 8,969 | $376K | |
| 2021 | 11,564 | $506K | |
| 2022 | 16,147 | $647K | |
| 2023 | 15,349 | $703K | |
| 2024incomplete | 14,282 | $653K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 6,171 | 5,070 | $862K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 5,483 | 4,002 | $829K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 13% | 5,405 | 726 | $624K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 3,168 | 2,233 | $589K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.6% | 2,093 | 1,723 | $167K |
| 87428 | 3.3% | 2,999 | 2,472 | $153K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.1% | 1,614 | 1,255 | $144K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.6% | 3,224 | 2,443 | $123K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 5,597 | 3,387 | $99K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 2,863 | 597 | $95K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 7,207 | 5,697 | $89K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.9% | 1,100 | 1,039 | $87K |
68 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.8% | 2,023 | $83K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 2,143 | $68K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 1,752 | $68K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 3,231 | $66K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.0% | 570 | $47K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 408 | $42K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 531 | $40K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,131 | $39K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,062 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,662 | $33K |
| 80053 | Comprehensive metabolic panel | <1% | 4,556 | $29K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 972 | $27K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 352 | $24K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 497 | $23K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 767 | $23K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 520 | $23K |
| 83880 | <1% | 697 | $17K | |
| 84484 | <1% | 2,309 | $15K | |
| 81025 | <1% | 1,694 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,580 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,439 | $10K |
| 74018 | <1% | 191 | $9K | |
| 81001 | <1% | 3,429 | $8K | |
| 80305 | <1% | 789 | $7K | |
| 83735 | <1% | 1,598 | $7K | |
| 87807 | <1% | 628 | $6K | |
| Q3014 | Telehealth originating site facility fee | <1% | 349 | $6K |
| 87634 | <1% | 95 | $6K | |
| 87081 | <1% | 836 | $5K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 32 | $5K |
| 81003 | <1% | 2,265 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 704 | $4K |
| 82553 | <1% | 350 | $3K | |
| 87186 | <1% | 391 | $3K | |
| 87077 | <1% | 415 | $3K | |
| 73560 | <1% | 70 | $3K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 17 | $2K |
| 87088 | <1% | 272 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 220 | $2K |
| 87040 | <1% | 281 | $2K | |
| 83690 | <1% | 347 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 227 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 14 | $1K |
| 82550 | <1% | 228 | $1K | |
| 87210 | <1% | 382 | $1K | |
| 85610 | <1% | 429 | $1K | |
| 85730 | <1% | 232 | $965.28 | |
| 74022 | <1% | 15 | $868.05 | |
| 85378 | <1% | 159 | $848.79 | |
| 73030 | <1% | 34 | $802.41 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 26 | $799.00 |
| 97161 | <1% | 16 | $790.53 | |
| 83605 | <1% | 86 | $783.58 | |
| 83874 | <1% | 75 | $773.62 | |
| 73630 | <1% | 15 | $770.62 | |
| 82962 | <1% | 201 | $578.93 | |
| 94761 | <1% | 251 | $507.45 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 30 | $363.37 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 975 | $85.14 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 263 | $77.19 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 712 | $71.54 |
| 82150 | <1% | 13 | $64.80 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,152 | $61.17 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 714 | $33.75 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 1,533 | $0.00 |
| J3490 | Unclassified drugs | 0% | 1,677 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 231 | $0.00 |
| J8597 | Antiemetic drug, oral, not otherwise specified | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Rush Medical Foundation | Meridian, MS | $29.41M |
| Laird Hospital, INC. | Union, MS | $7.23M |
| Laird Hospital, INC. | Meridian, MS | $5.90M |
| Laird Hospital, INC | Meridian, MS | $5.27M |
| Kemper, Cah, INC | Livingston, AL | $4.50M |
| Medical Foundation, INC. | Meridian, MS | $4.20M |
| Kemper Cah, INC. | De Kalb, MS | $4.06M |
| Scott Regional Medical Center, INC. | Morton, MS | $3.77M |
| Kemper Cah, INC | Meridian, MS | $3.39M |
| Rush Hospital/Butler, INC | Butler, AL | $1.94M |
| Medical Foundation, INC. | Meridian, MS | $1.82M |
| The Medical Store, INC. | Meridian, MS | $1.66M |
| Rush Medical Foundation | Meridian, MS | $1.61M |
| Medical Foundation, INC. | Meridian, MS | $1.37M |
| Laird Hospital, INC. | Union, MS | $1.31M |
| Medical Foundation, INC. | Meridian, MS | $1.27M |
| Scott Regional Medical Center, INC. | Morton, MS | $1.21M |
| Rush Medical Foundation | Quitman, MS | $978K |
| Kemper Cah, INC | Meridian, MS | $910K |
| Laird Hospital, INC. | Philadelphia, MS | $898K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.